Assessment of suitability of the one step nucleic acid amplification (OSNA) assay as an intraoperative procedure for detection of metastasis in sentinel lymph nodes of breast cancer

Journal of Clinical Pathology

Volumn 67, Issue 12, 2014, Pages 1032-1037

  Jara Lazaro, Ana Richelia ^a   Hussain, Ilyana Huda Mohamed ^a   Thike, Aye Aye ^a   Wong, Chow Yin ^a   Ho, Gay Hui ^b   Yong, Wei Sean ^b   Ong, Kong Wee ^b   Madhukumar, Preetha ^b   Tan, Benita Kiat Tee ^a   Oey, Chung Lie ^a   Hwang, Jacqueline Siok Gek ^a   Tan, Puay Hoon ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FROZEN SECTION; HISTOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; NUCLEIC ACID AMPLIFICATION; ONE STEP NUCLEIC ACID AMPLIFICATION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE METASTASIS; TURNAROUND TIME; BREAST TUMOR; DIAGNOSTIC USE; FEMALE; LYMPHATIC METASTASIS; PATHOLOGY; PROCEDURES; SENTINEL LYMPH NODE BIOPSY; TIME;

CYTOKERATIN 19; TUMOR MARKER;

BREAST NEOPLASMS; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; KERATIN-19; LYMPHATIC METASTASIS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84910126381     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2014-202361     Document Type: Article

References (31)

1. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-20.
2. Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases. The American College of Surgeons Oncology Group Z0011 Randomized Trial. Ann Surg 2010;252:426-33.
3. McMasters KM, Tuttlw TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18:2560-6.
4. Lee KC, Yong WS, HO BCS, et al. False negatives in the intra-operative frozen section of sentinel lymph nodes for breast carcinoma. SGH Proceedings 2008;17:P-CLI-276.
5. Alvarenga CA, Paravidino PI, Alvarenga M, et al. Expression of CK19 in invasive breast carcinomas of special histological types: implications for the use of one-step nucleic acid amplification. J Clin Pathol 2011;64:493-7.
6. Weigelt B, Verduijn P, Bosma AJ, et al. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers. Br J Cancer 2004;90:1531-7.
7. Tsujimoto M, Nakabayashi K, Yoshidome K, et al. One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res 2007;13:4807-16.
8. Gimbergues P, Dauplat MM, Cayre A, et al. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category. Eur J Surg Oncol 2007;33:16-22.
9. Tamaki Y, Akiyama F, Iwase T, et al. Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay. Clin Cancer Res 2009;15:2879-84.
10. Schem C, Maass N, Bauerschlag DO, et al. One-step nucleic acid amplification - a molecular method for the detection of lymph node metastases in breast cancer patients: results of the German study group. Virchows Arch 2009;454:203-10.
11. Osako T, Iwase T, Kimura K, et al. Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer: a comparative analysis between one-step nucleic acid amplification whole node assay and routine frozen section histology. Cancer 2011;117:4365-74.
12. Greene FL. Breast tumours. In: Sobin LH, Gospodarowicz MK, Wittekind C, eds. TNM classification of malignant tumours. 7th edn. Oxford: Wiley-Blackwell, 2009:181-93.
13. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
14. Wang YS, Ou-Yang T, Wu J, et al. Comparative study of one-step nucleic acid amplification assay, frozen section and touch imprint cytology for intraoperative assessment of breast sentinel lymph node in Chinese patients. Cancer Sci 2012;103:1989-93.
15. Tamaki Y, Sato N, Homma K, et al. Routine clinical use of the one-step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients: results of a multicenter study in Japan. Cancer 2012;118:3477-83.
16. Le Frère-Belda MA, Bats AS, Gillaizeau F, et al. Diagnostic performance of one-step nucleic acid amplification for intraoperative sentinel node metastasis detection in breast cancer patients. Int J Cancer 2012;130:2377-86.
17. Snook KL, Layer GT, Jackson PA, et al. Multicentre evaluation of intraoperative molecular analysis of sentinel lymph nodes in breast carcinoma. Br J Surg 2011;98:527-35.
18. Visser M, Jiwa M, Horstman A, et al. Intraoperative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer 2008;122:2562-7.
19. Bernet L, Cano R, Martinez M, et al. Diagnosis of the sentinel lymph node in breast cancer: a reproducible molecular method: a multicentric Spanish study. Histopathology 2011;58:863-9.
20. Godey F, Leveque J, Tas P, et al. Sentinel lymph node analysis in breast cancer: contribution of one-step nucleic acid amplification (OSNA). Breast Cancer Res Treat 2012;131:509-16.
21. Osako T, Iwase T, Kimura K, et al. Incidence and possible pathogenesis of sentinel node micrometastases in ductal carcinoma in situ of the breast detected using molecular whole lymph node assay. Br J Cancer 2012;106: 1675-81.
22. Castellano I, Macri L, Deambrogio C, et al. Reliability of whole sentinel lymph node analysis by one-step nucleic amplification for intraoperative diagnosis of breast cancer metastases. Ann Surg 2012;255:334-42.
23. Ohi Y, Umekita Y, Sagara Y, et al. Whole sentinel lymph node analysis by a molecular assay predicts axillary node status in breast cancer. Br J Cancer 2012;207:1239-43.
24. Feldman S, Krishnamurthy S, Gillanders W, et al. A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodes. Cancer 2011;117:2599-607.
25. Suyoi A, Bains SK, Kothari A, et al. When is a completion axillary lymph node dissection necessary in the presence of a positive sentinel lymph node? Eur J Cancer 2014;50:690-7.
26. Cserni G. Intraoperative analysis of sentinel lymph nodes in breast cancer by one-step nucleic acid amplification. J Clin Pathol 2012;65:193-9.
27. Maiorano E, Mazzarol GM, Pruneri G, et al. Ectopic breast tissue as a possible cause of false-positive axillary sentinel lymph node biopsies. Am J Surg Pathol 2003;27:513-18.
28. Horvath JW, Barnett GE, Jimenez RE, et al. Comparison of intraoperative frozen section analysis for sentinel lymph node biopsy during breast cancer surgery for invasive lobular carcinoma and invasive ductal carcinoma. World J Surg Oncol 2009;7:34.
29. Pechlivanides G, Vassilaros D, Tsimpanis A, et al. Sentinel node biopsy for breast cancer patients: issues for discussion and our practice. Patholog Res Int 2010;2011:109712.
30. Shiller SM, Weir R, Pippen J, et al. The sensitivity and specificity of sentinel lymph node biopsy for breast cancer at Baylor University Medical Center at Dallas a retrospective review of 488 cases. Proc (Bayl Univ Med Cent) 2011;24: 81-5.
31. Guillen-Paredes MP, Carrasco-Gonzalez L, Chaves-Benito A, et al. One-step nucleic acid amplification (OSNA) assay for sentinel lymph node metastases as an alternative to conventional postoperative histology in breast cancer: a cost-benefit analysis. Cir Esp 2011;89:456-62.